Tarsus Pharmaceuticals Inc (TARS)
46.65
+0.15
(+0.32%)
USD |
NASDAQ |
Nov 14, 16:00
46.49
-0.16
(-0.34%)
After-Hours: 16:45
Tarsus Pharmaceuticals Profit Margin (Quarterly): -81.57% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -81.57% |
| March 31, 2024 | -129.4% |
| December 31, 2023 | -320.4% |
| September 30, 2023 | -2.09K% |
| June 30, 2023 | |
| March 31, 2023 | -936.8% |
| December 31, 2022 | -136.0% |
| Date | Value |
|---|---|
| September 30, 2022 | |
| June 30, 2022 | -37.59% |
| March 31, 2022 | -3.75K% |
| December 31, 2021 | -4.39K% |
| September 30, 2021 | -1.27K% |
| June 30, 2021 | 28.82% |
| March 31, 2021 | 31.04% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.39K%
Minimum
Dec 2021
31.04%
Maximum
Mar 2021
-1.09K%
Average
-228.2%
Median
Profit Margin (Quarterly) Benchmarks
| Amicus Therapeutics Inc | -4.75% |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -3.67K% |
| IGC Pharma Inc | -874.3% |
| NovaBay Pharmaceuticals Inc | -66.04% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -69.10% |
| Return on Assets | -51.79% |
| Return on Invested Capital | -59.01% |
| Gross Profit Margin (Quarterly) | 92.64% |
| Operating Margin (Quarterly) | -81.60% |
| Return on Net Operating Assets | -465.7% |